ProShares UltraShort Health Care
3 hedge funds and large institutions have $210K invested in ProShares UltraShort Health Care in 2020 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
118% more call options, than puts
Call options by funds: $28.8M | Put options by funds: $13.2M
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
50% more funds holding
Funds holding: 2 → 3 (+1)
3.21% less ownership
Funds ownership: 5.31% → 2.09% (-3.2%)
62% less capital invested
Capital invested by funds: $559K → $210K (-$349K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$201K |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
+$10.6K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$2.06K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$540K |
RXD Hedge Fund Activity: Q2 2020 in Review
3 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in ProShares UltraShort Health Care (RXD) for Q2 2020, worth a combined $210K — down 62% from $559K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new RXD positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $201K. The largest seller was Citadel Advisors, exiting entirely with an estimated $540K sold.
- 3 institutional investors held ProShares UltraShort Health Care (RXD) as of Q2 2020, up from 2 in Q1 2020.
- Funds reported $210K of ProShares UltraShort Health Care stock for Q2 2020, down 62% quarter-over-quarter.
- 2 funds opened new ProShares UltraShort Health Care positions in Q2 2020 and 1 closed out, a net change of +1 holder.
- The largest ProShares UltraShort Health Care buyer in Q2 2020 was Susquehanna International Group, an estimated $201K added.
- The largest ProShares UltraShort Health Care seller in Q2 2020 was Citadel Advisors, an estimated $540K sold.
Based on aggregated 13F filings for Q2 2020.